Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publisher Correction: ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques

Journal article

van Doremalen N. et al, (2021), Nature, 590, E24 - E24

ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques

Journal article

van Doremalen N. et al, (2020), Nature, 586, 578 - 582

A single dose of ChAdOx1 MERS provides protective immunity in rhesus macaques

Journal article

van Doremalen N. et al, (2020), Science Advances, 6

A defined mechanistic correlate of protection against Plasmodium falciparum malaria in non-human primates

Journal article

Douglas AD. et al, (2019), Nature Communications, 10

Safety and Immunogenicity of a Novel Recombinant Simian Adenovirus ChAdOx2 as a Vectored Vaccine

Journal article

Folegatti PM. et al, (2019), Vaccines, 7, 40 - 40

SAFETY AND IMMUNOGENICITY OF THE NOVEL PLASMODIUM FALCIPARUM BLOOD-STAGE VACCINE CHAD63-MVA RH5 IN A PHASE IA CLINICAL TRIAL

Conference paper

Payne R. et al, (2017), AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 95, 313 - 313

Viral Vector Malaria Vaccines Induce High-Level T Cell and Antibody Responses in West African Children and Infants

Journal article

Bliss CM. et al, (2017), Molecular Therapy, 25, 547 - 559

HIGH LEVEL EFFICACY IN HUMANS OF A NEXT-GENERATION PLASMODIUM FALCIPARUM ANTI-SPOROZOITE VACCINE: R21 IN MATRIX-M (TM) ADJUVANT

Conference paper

Venkatraman N. et al, (2017), AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 97, 594 - 594

PROBABILITY OF TRANSMISSION OF MALARIA FROM MOSQUITO TO HUMAN IS REGULATED BY PARASITE DENSITY IN NAIVE AND VACCINATED HOSTS

Conference paper

Churcher TS. et al, (2017), AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 97, 230 - 230

A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA

Journal article

Ewer K. et al, (2016), New England Journal of Medicine, 374, 1635 - 1646

External Quality Assurance of Malaria Nucleic Acid Testing for Clinical Trials and Eradication Surveillance

Journal article

Murphy SC. et al, (2014), PLoS ONE, 9, e97398 - e97398

Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation

Journal article

Ewer KJ. et al, (2013), Nature Communications, 4

Comparison of Modeling Methods to Determine Liver-to-blood Inocula and Parasite Multiplication Rates During Controlled Human Malaria Infection

Journal article

Douglas AD. et al, (2013), The Journal of Infectious Diseases, 208, 340 - 345

Evaluation of the Safety and Immunogenicity of a Candidate Tuberculosis Vaccine, MVA85A, Delivered by Aerosol to the Lungs of Macaques

Journal article

White AD. et al, (2013), Clinical and Vaccine Immunology, 20, 663 - 672

Comparison of Clinical and Parasitological Data from Controlled Human Malaria Infection Trials

Journal article

Roestenberg M. et al, (2012), PLoS ONE, 7, e38434 - e38434

Clinical Assessment of a Recombinant Simian Adenovirus ChAd63: A Potent New Vaccine Vector

Journal article

O’Hara GA. et al, (2012), The Journal of Infectious Diseases, 205, 772 - 781